Summary
We report on a meta-analysis of four randomized, placebo-controlled, double-blind multicenter trials evaluating the role of perioperative octreotide treatment in the prevention of postoperative complications following elective pancreatic surgery. From a total of 963 patients (483 placebo, 480 octreotide), the postoperative complication rate (329 placebo, 206 octreotide) and the number of patients with postoperative complications (placebo 38%, octreotide 22%) were significantly higher in the placebo groups compared with the octreotide groups. Postoperative mortality was comparable between the placebo (3.9%) and the octreotide (3.5%) groups. These data indicate that perioperative application of octreotide can prevent postoperative complications following pancreatic surgery.
Zusammenfassung
In vier randomisierten, plazebo-kontrollierten, doppelblinden Multizenterstudien wurde die Wertigkeit einer perioperativen Pankreas-Sekretionshemmung mit Octreotid in der elektiven Pankreaschirurgie untersucht. Die Anzahl von postoperativen Komplikationen (329 Plazebo, 206 Octreotid) als auch die Anzahl von Patienten mit postoperativen Komplikationen (Plazebo 38%, Octreotid 22%) waren in den Plazebo-gruppen signifikant höher als in den Octreotidgruppen. Die Krankenhausmortalität war in beiden Gruppen nicht unterschiedlich (Plazebo 3.9%, Octreotid 3.5%). Diese Ergebnisse zeigen, daß eine perioperative Sekretionshemmung mit Octreotid, postoperative Komplikationen in der elektiven Pankreaschirurgie reduziert.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bartoli FG, Arnone GB, Ravera G, Bachi V. (1991) Pancreatic fistula and relative mortality in malignant disease after pancreaticoduodenectomy. Review and statistical metaanalysis regarding 15 years of literature. Anticancer Res 11:1831–1848
Büchler MW, Friess H, Klempa I, Hermanek P, Sulkowski U, Becker H, Schafmayer A, Baca I, Lorenz D, Meister R, Kremer B, Wagner P, Witte J, Zurmayer EL, Saeger HD, Rieck B, Dollinger P, Glaser K, Teichmann R, Konradt J, Gaus W, Dennler HJ, Welzel D, Beger HG (1992) Role of Octreotide in the Prevention of Postoperative Complications Following Pancreatic Resection. Am J Surg 163:125–131
Pederzoli P, Bassi C, Falconi M, Gamboni MG (1994) Efficacy of Octreotide in the prevention of complications of elective pancreatic surgery. Br J Surg 81:265–269
Montorsi M, Zago M, Mosca F, Capussotti L, Zotti E, Ribotta G, Fegiz G, Fissi S, Roviaro G, Per-acchia A, Pivi M, Perego R, Pezzuoli G (1995) Efficacy of Octreotide in the prevention of pancreatic fistula after elective pancreatic resections: A prospective, controlled, randomized clinical trial. Surgery 117:26–31
Friess H, Beger HG, Sulkowski U, Becker H, Hofbauer B, Dennler HJ, Büchler MW (1995) Randomized controlled multicenter study of the prevention of complications by Octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg 82:1270–1273
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Friess, H., Uhl, W., Schilling, M., Büchler, M.W. (1996). Sekretionshemmung in der Pankreaschirurgie reduziert die postoperative Komplikationsrate: Eine Metaanalyse von vier Multizenterstudien. In: Hartel, W. (eds) Wahrung des Bestandes, Wandel und Fortschritt der Chirurgie. Langenbecks Archiv für Chirurgie, vol 1996. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80295-9_63
Download citation
DOI: https://doi.org/10.1007/978-3-642-80295-9_63
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61617-7
Online ISBN: 978-3-642-80295-9
eBook Packages: Springer Book Archive